19 citations
,
August 2011 in “Archives of Dermatology” This abstract contains no research findings but is a snippet of a website interface for JAMA Dermatology.
19 citations
,
October 1994 in “Tumori Journal” This review discusses the current medical treatments for hepatocellular carcinoma, noting that while new local therapies show high response rates, their true impact on patient survival is uncertain.
7 citations
,
December 2011 in “Elsevier eBooks” The document concludes that early diagnosis and treatment are crucial for managing skin diseases in ferrets.
4 citations
,
October 1998 in “In Practice” This article outlines a practical method for diagnosing and managing feline symmetrical alopecia but presents no new empirical findings.
2 citations
,
January 2017 in “International Journal of Trichology” This case report describes the trichoscopic and histological features observed in a 7-year-old boy with morphea en coup de sabre and details the positive response to systemic immunosuppressive therapy.
1 citations
,
December 2021 in “Medical Records” This study found that during the COVID-19 pandemic, there was a significant reduction in dermatology clinic visits, with an increase in stress-induced dermatoses and more male patients seeking dermatological care compared to the previous year.
1 citations
,
October 1996 in “Journal of Cutaneous Medicine and Surgery” This review discusses the advancements needed for gene therapy to become commonly used in dermatology and reports no new clinical results.
July 2026 in “Archives of Dermatological Research” This study explores the potential of adaptogenic herbal extracts like ashwagandha, rhodiola, and schisandra in treating stress-induced dermatoses, noting their effects on modulating the HPA axis, reducing inflammation, and improving skin barrier function.
February 2026 in “Mendeley Data” This study, accepted for publication in the Journal of the American Academy of Dermatology, discusses the potential link between early androgenetic alopecia, diabetes mellitus, and cardiovascular disease risks, exploring its role as an indicator in a cross-sectional analysis.
February 2026 in “Acta Dermato Venereologica” In this study, a survey in Norway and Sweden among adults with self-reported alopecia areata revealed a substantial economic burden with annual mean costs of €7,677 in Norway and €12,582 in Sweden, largely due to indirect costs from reduced productivity.
June 2025 in “Academic Medical Journal” This study suggests elevated homocysteine levels may serve as a biomarker for disease severity and vascular risk in cutaneous lupus erythematosus, indicating potential therapeutic benefits from B-vitamin supplementation and lifestyle changes.
May 2025 in “Research Journal of Biotechnology” This study found that diabetic individuals experienced significant changes in hair characteristics, including reduced thickness, strength, and altered growth cycle phases, correlated with poor glycaemic control and haematological variations compared to healthy controls.
March 2025 in “Meditsinskiy sovet = Medical Council” In this article, researchers explore the causes, diagnostic approaches, and treatment strategies for diffuse telogen alopecia, emphasizing the importance of identifying triggers such as stress and metabolic disorders to effectively manage this hair loss condition.
December 2024 in “Archiv Euromedica” This review highlights that diagnosing cicatricial alopecia, a hair loss condition linked to several autoimmune diseases, requires trichoscopy and histopathological examination to differentiate it from similar conditions, with early diagnosis being crucial for effective management.
May 2024 in “Rossijskaâ oftalʹmologiâ onlajn” In this case report, a 17-year-old Korean female with Vogt–Koyanagi–Harada syndrome showed positive improvement in her symptoms following systemic glucocorticosteroid pulse therapy, highlighting the rarity and importance of early disease detection.
January 2024 in “JAAD case reports” Netherton syndrome can cause severe and chronic vulvovaginal symptoms that may improve with continuous oral contraceptives.
This case study reports clinical improvement and complete ulcer resolution in a 29-year-old woman with ANA-negative SLE treated for segmental hyalinizing vasculitis and valvular heart disease.
This case series observed that patients with persistent post-COVID-19 symptoms reported considerable improvement after using icosapent ethyl, suggesting potential therapeutic success warranting further research.
January 2015 in “Journal of the turkish academy of dermatology” This review discusses the evidence and literature on phototherapy for vitiligo but reports no novel clinical findings, highlighting the treatment's reliance on melanocyte reservoirs for repigmentation.
February 2004 in “The New England Journal of Medicine” The book is a comprehensive resource on hair disorders, but lacks information on some conditions.
June 2017 in “International Journal of Research in Dermatology” In this study, researchers observed that skin conditions in Timbi are influenced by occupation, literacy, and systemic diseases, with widespread improper steroid use contributing to complications.
151 citations
,
July 2011 in “Archives of Dermatological Research” This review discusses various strategies to enhance drug delivery through the skin barrier, highlighting liposomes as promising carriers for increased dermal concentrations in topical therapies, but reports no new research results.
3 citations
,
July 2004 in “SKINmed/Skinmed” This case study describes a 4-year-old girl's diagnosis of erythrokeratodermia variabilis despite various ineffective treatments, highlighting a rare skin condition with persistent symptoms.
1 citations
,
January 2015 in “Springer eBooks” Chemotherapy can cause skin side effects that affect patients' lives, but they can be managed to avoid interrupting cancer treatment.
June 2022 in “Indian journal of clinical and experimental opthalmology” This case report details the ocular complications of Hutchinson-Gilford Progeria syndrome in a 20-year-old Bangladeshi patient, highlighting symptoms like dry eyes, Meibomian gland dysfunction, and cataracts.
January 2025 in “Updates in clinical dermatology” This study highlights that the skin can serve as a marker for systemic health during COVID-19 by showing symptoms like rashes and pigmentary changes, while also emphasizing dermatologists' key role in diagnosing COVID-induced and vaccine-related skin issues to enhance patient care and address vaccine hesitancy.
2 citations
,
August 2025 in “Scientific Reports” This study analyzed pexidartinib-associated adverse events from FDA data and reported common events such as hepatic issues and systemic reactions. It highlighted sex-specific susceptibilities and reinforced the need for risk mitigation and long-term monitoring in tenosynovial giant cell tumor management.
January 2026 in “IECCMEXICO” This review highlights how chronic inflammatory skin disorders like psoriasis and atopic dermatitis may be better understood as manifestations of systemic immune dysregulation rather than just skin issues, suggesting that recognizing these conditions as markers of broader immune imbalance can improve diagnosis and medical education.
11 citations
,
January 2013 in “Indian Journal of Endocrinology and Metabolism” This study concluded that mucocutaneous symptoms can assist in diagnosing diabetes mellitus and its complications, highlighting the potential for dermatologists to detect related systemic issues early in patients.
2 citations
,
October 2024 in “Journal of Cosmetic Dermatology” This study highlights that chemicals used in brow lamination, like ammonium thioglycolate and thioglycolic acid, may cause skin irritation and other systemic issues, suggesting a need for further investigation and regulatory measures.